How many insider trades does FilingIQ track for NPHC?

FilingIQ tracks 7 Form 4 insider transactions for NPHC (NUTRA PHARMA CORP), covering filings from Apr 10, 2014 onwards. 1 of those were filed in the last 90 days.

Are NPHC insiders net buyers or net sellers?

Across the full Form 4 history for NPHC, 3 transactions (43%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NPHC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NPHC in?

NUTRA PHARMA CORP (NPHC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.42M.

NPHC insider trading

Healthcare

NUTRA PHARMA CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

43% / 0%

Market cap

$1.42M

About NUTRA PHARMA CORP

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin, an over-the-counter (OTC) pain reliever; Nyloxin Extra Strength, a non-narcotic and non-addictive treatment for severe pain; Pet Pain-Away, an OTC pain reliver for dogs and cats; Equine Pain-Away, an OTC topical pain reliever to relieve pain in horses; and Luxury Feet, an OTC pain reliever for foot pain from high heels and stilettos. It is also involved in developing RPI-78M to treat neurological and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, and general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Boca Raton, Florida.

Company website: www.nutrapharma.com

NPHC insider activity at a glance

FilingIQ has scored 7 insider transactions for NPHC since Apr 10, 2014. The most recent filing in our index is dated Aug 21, 2026.

Across the full history, 3 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NPHC insider trades is 67.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NPHC trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 805

UNITED THERAPEUTICS Corp

BLLN 188

BillionToOne, Inc.

KYMR 166

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

HNGE 122

Hinge Health, Inc.

GH 120

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for NPHC?: FilingIQ tracks 7 Form 4 insider transactions for NPHC (NUTRA PHARMA CORP), covering filings from Apr 10, 2014 onwards. 1 of those were filed in the last 90 days.
Are NPHC insiders net buyers or net sellers?: Across the full Form 4 history for NPHC, 3 transactions (43%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NPHC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NPHC in?: NUTRA PHARMA CORP (NPHC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.42M.

Methodology & sources

Every NPHC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.